Mechanism of Action - The Excitement Blockers
- Glutamate: The primary excitatory neurotransmitter in the CNS. It acts as the brain's main "gas pedal."
- Its overactivity can lead to seizures.
- 📌 Mnemonic: GlutaMATE is an EXCITING guy!
- Key Receptors: Glutamate binds to ionotropic receptors that, when activated, allow positive ions to flow into the neuron, causing excitation.
- AMPA Receptors: Mediate fast synaptic transmission by allowing $Na^{+}$ influx.
- NMDA Receptors: Gate both $Na^{+}$ and $Ca^{2+}$. Require glycine as a co-agonist.

⭐ High-Yield Fact: Beyond seizures, blocking NMDA receptors is crucial for preventing excitotoxicity, the neuronal death caused by prolonged excitatory stimulation, often seen in status epilepticus and stroke.
The Drugs - Rogues' Gallery of Antagonists
- Core Mechanism: Glutamate is the brain's main "on" switch. These drugs work by antagonizing its receptors (NMDA & AMPA), thus dampening neuronal hyperexcitability and stopping seizure propagation.
| Drug | Target | Clinical Use | Key Adverse Effects |
|---|---|---|---|
| Perampanel | AMPA Receptor (non-competitive antagonist) | Focal-onset seizures (adjunctive, with or without secondary generalization), Primary generalized tonic-clonic seizures. | Dizziness, somnolence, headache. ⚠️ Black Box Warning: Serious dose-related psychiatric/behavioral changes (aggression, hostility, homicidal ideation). |
| Felbamate | NMDA Receptor (modulates glycine binding site) | Refractory seizures, particularly in Lennox-Gastaut syndrome. | ⚠️ Black Box Warnings: Aplastic anemia (risk ~1:3,600) and acute hepatic failure. Use is severely restricted. |
| Topiramate | AMPA/Kainate Receptors, VGSCs, GABA-A agonist | Broad-spectrum antiepileptic (focal & generalized), migraine prophylaxis, weight loss. | Cognitive slowing ("Dopamax"), paresthesias, weight loss, metabolic acidosis, nephrolithiasis. |
📌 PERAmpanel causes PERAnoia (psychiatric side effects) by blocking AMPA.
Clinical Use & Cautions - Prescribing Playbook
-
Felbamate
- Use: Reserved for refractory seizures (e.g., Lennox-Gastaut syndrome) due to its risk profile.
- Cautions: ⚠️ Black Box Warnings for aplastic anemia and acute hepatic failure. Requires signed patient consent.
-
Perampanel (AMPA receptor antagonist)
- Use: Adjunctive therapy for focal-onset and primary generalized tonic-clonic seizures in patients aged ≥ 12.
- Cautions: ⚠️ Black Box Warning for serious, dose-related psychiatric and behavioral adverse reactions (e.g., aggression, hostility, homicidal ideation).
-
Topiramate
- Use: Broad-spectrum agent for focal and generalized seizures; also used for migraine prophylaxis.
- Cautions: Can cause cognitive slowing ("Dopamax"), metabolic acidosis, kidney stones, and acute angle-closure glaucoma. Promotes weight loss.
-
Lamotrigine
- Use: Broad-spectrum for focal, generalized, and absence seizures; also a key mood stabilizer in bipolar disorder.
- Cautions: ⚠️ Black Box Warning for serious skin rashes (SJS/TEN).
⭐ The risk of SJS/TEN with Lamotrigine is significantly increased by co-administration with valproate (which inhibits its metabolism) and by rapid dose escalation.
High-Yield Points - ⚡ Biggest Takeaways
- Glutamate antagonists reduce neuronal excitability by blocking the brain's primary excitatory neurotransmitter, targeting AMPA or NMDA receptors.
- Felbamate is reserved for refractory seizures (e.g., Lennox-Gastaut) due to high risks of aplastic anemia and hepatic failure.
- Topiramate also blocks AMPA/kainate receptors; watch for cognitive slowing ("dopiramate"), kidney stones, and metabolic acidosis.
- Perampanel is a selective AMPA antagonist with a black box warning for serious psychiatric and behavioral reactions.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more